GMED vs NTAP · P/E 42, rev $1.55B vs P/E 28, rev $6.24B
Globus Medical (GMED) versus NetApp Inc (NTAP) — a side-by-side from cached financials, not a winner call.
Globus Medical (GMED) is a medical devices company listed on US.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
GMED currently screens at market cap $7.66B and trailing P/E 42.1. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Not investment advice. Open the GMED and NTAP stock pages for the full models.
Not investment advice.